Seattle area EndoGastric Solutions raises $30.5M for acid reflux treatment

EndoGastric Solutions, a Seattle area biotechnology company, has raised $30.5 million to scale its commercial efforts. Existing investors Advanced Technology Ventures (ATV), Canaan Partners, Canepa Healthcare, Chicago Growth Partners, CRG, Radius Ventures and Sightline Partners took part in the round, along with a number of unnamed new investors. The company said in a statement that the cash will support wider commercialization of its treatment for chronic acid reflux, which is already on the market.